INS and gestational diabetes: In the middle and late stages of pregnancy, anti-insulin-like substances such as progesterone and estrogen are elevated in the pregnant women’s bodies, which affects the sensitivity to insulin and increases the amount of insulin secreted, which is insufficient to compensate for the combined insulin defects, thus leading to the emergence of GDM (95).